Clinical Trials Directory

Trials / Completed

CompletedNCT02615912

A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Kimberly-Clark Corporation · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to understand the changes in skin microflora, skin barrier function, and skin biochemical constituents in response to direct contact with model surfactants used in personal care articles. The results from this study will provide insights into the complex interaction between the skin microbiome and the epidermis after exposure to surfactants.

Conditions

Interventions

TypeNameDescription
OTHERPEG-40 Hydrogenated Castor Oil (Tagat CH40, Evonik) 1.5%
OTHERLauryl glucoside (Plantacare® 1200UP, BASF) 1.5%
OTHERSorbitan palmitate (SPANTM 40 (powder), Croda) 1.5%
OTHERSilwet* DA-63 (Momentive) 1.5%
OTHERSodium lauryl sulfate (Sigma Aldrich) 1.0%
OTHERWater (control)

Timeline

Start date
2015-11-01
Primary completion
2015-12-01
Completion
2016-02-01
First posted
2015-11-26
Last updated
2016-09-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02615912. Inclusion in this directory is not an endorsement.